- Increase in dividend to EUR 0.75 per share
- Large majority for resolution approving work of Management Board and Supervisory Board
- Gerresheimer takes leave of long-time Supervisory Board Chairman Gerhard Schulze
- Andrea Abt new member of the Supervisory Board for shareholders
Duesseldorf, April 30, 2015 – A dividend of EUR 0.75 per share was approved at the Annual General Meeting of Gerresheimer AG held today in Duesseldorf. The MDAX-listed Group manufactures glass and plastic pharma packaging together with products for safe and simple drug delivery such as insulin pens, inhalers and syringes.
“2014 was a good year for Gerresheimer AG. We grew as expected in terms of both revenues and earnings. 2014 saw us launch key investment projects, paving the way for further profitable growth. Accordingly, we proposed a further increase in the dividend to EUR 0.75 per share, and this was approved by a large majority at today’s Annual General Meeting,” said Uwe Röhrhoff, CEO of Gerresheimer AG, summing up at the Annual General Meeting. “I would like to thank our longstanding Chairman of the Supervisory Board, Gerhard Schulze, for his excep-tional dedication and his tireless hard work for Gerresheimer AG. Mr. Schulze has worked for the benefit of the Company in various positions for more than 47 years. From 2008, he did so with great success as Chairman of the Supervisory Board.”
The dividend of EUR 0.75 per dividend-entitled share will be paid out on May 4, 2015. This amount represents an increase of 7.1% against the prior year, when a dividend of EUR 0.70 per share was distributed.
A large majority voted in favor of the resolution formally approving the acts of the Management Board and Supervisory Board in financial year 2014. Andrea Abt was elected by a large majority at the Annual General Meeting as a new member of the Supervisory Board for shareholders. The Management Board remuneration system was likewise approved by a large majority at the Annual General Meeting. Deloitte & Touche GmbH Wirtschaftsprüfungsgesellschaft, Duesseldorf, was elected as auditor for financial year 2015.
78.54% of the capital stock was represented at today’s Annual General Meeting. The detailed voting results on all items of the Annual General Meeting agenda are available here: Annual General Meeting
The speech delivered at the Annual General Meeting is available here: Annual General Meeting
The Annual Report is available here: Reports
About Gerresheimer
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with 11,000 employees and manufacturing operations in the local markets, close to customers. It has over 40 production facilities in Europe, North and South America and Asia generating revenue in excess of EUR 1.3 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug-delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.
